Related Experiment Video
Updated: Mar 18, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
D-Dimer: A Mediator of the Association Between Lymphocyte and Dissemination of Pulmonary Tuberculosis: A
Yujun Lin1,2,3, Di Wu4, Xiaohong Chen4
1Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital, Fujian Medical University, Quanzhou City, Fujian, China.
Introduction:
This study aimed to examine whether D-dimer and lymphocyte counts predict the risk of concurrent pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) and to identify critical thresholds for clinical use. We also investigated whether D-dimer mediates the protective effect of lymphocytes against tuberculosis (TB) dissemination.
Methods:
One thousand nine hundred (1318 PTB and 582 PTB + EPTB) patients diagnosed between 2022 and 2024 were analyzed. Multiple regression analysis, smooth curve fitting, threshold effect analysis, and causal mediation analysis were conducted using EasyStat and R software to evaluate the association between lymphocyte counts (exposure), D-dimer (mediator), and PTB + EPTB risk (outcome) and to determine the critical value of lymphocyte counts and D-dimer.
Results:
PTB + EPTB patients had higher D-dimer and lower lymphocyte counts. Elevated D-dimer increased the risk of PTB + EPTB (adjusted OR = 2.28, 95% CI: 1.99-2.60). High lymphocyte counts reduced the risk (adjusted OR = 0.25, 95% CI: 0.13-0.46). Threshold effects showed increased risk when D-dimer exceeded 0.170 mg/L (OR = 2.35, 95% CI: 2.05-2.70) and reduced risk when lymphocyte counts exceeded 750 cells/μL (OR = 0.15, 95% CI: 0.07-0.32). D-dimer mediated 36.473% (95% CI: 25.469-53.168) of the protective effect of lymphocytes.
Conclusions:
D-dimer is an independent risk factor and lymphocyte counts a protective factor for PTB + EPTB, with D-dimer mediating 36.473% of the lymphocyte effect. Clinically actionable thresholds (D-dimer > 0.170 mg/L and lymphocytes < 750 cells/μL) provide concrete targets for early intervention to prevent TB dissemination and improve outcomes.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

